Vitrolife AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 855 million compared to SEK 514 million a year ago. Net income was SEK 74 million compared to SEK 33 million a year ago.

Basic earnings per share from continuing operations was SEK 0.55 compared to SEK 0.26 a year ago.